St. Jude Medical Inc. is set to acquire Pleasanton-based and HeartMate maker Thoratec Corp. in a transaction valued at approximately $3.4 billion, or $63.50 per share. The boards of directors of both ...

Thoratec's HeartMate PHP is a heart pump intended for hemodynamic support in high-risk percutaneous coronary intervention (PCI) patients. HeartMate PHP received CE Mark in July 2015 but does not yet ...

D. Keith Grossman, president and CEO of the medical device company Thoratec, has no shortage of superlatives for Burnett, whom he hired nine years ago. Burnett was Thoratec's chief operating officer.

The pumps are driven by either pneumatic or electrical drive systems. Examples of this type of devices are the Thoratec pneumatic VAD (pVAD) and implantable VAD (IVAD; Thoratec Laboratories Corp ...

HeartMate II. The Heart- Mate II (Thoratec, Pleasanton, CA) is the most widely used implantable device, with more than 10,000 implants worldwide (as of April 2012). The HeartMate II is currently ...

A pair of heart devices linked to hundreds of injuries and at least 14 deaths has received the FDA's most serious recall, the ...

The HeartMate devices were developed by Thoratec, which St. Jude Medical bought in 2015 for $3.4 billion. Later, Abbott inherited the technology through its $25 billion acquisition of St. Jude Medical ...

Axess Technologies has secured a significant contract with HSM Offshore Energy for the installation of platform cables at the ...

Most notably the strategic investments and acquisition of CardioMEMS, the commercial launch of CardioMEMS and the acquisition of Thoratec that rounded out a new Heart Failure Business Unit within ...

The scope of work includes project management, engineering, pulling, terminating and testing the internal platform cables into the Thor offshore substation topside ...